Explore
Validate
Learn
Western blot
ELISAAntibody data
- Antibody Data
- Antigen structure
- References [13]
- Comments [0]
- Validations
- Western blot [1]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 11326-1-AP - Provider product page
- Provider
- Proteintech Group
- Proper citation
- Proteintech Cat#11326-1-AP, RRID:AB_10695624
- Product name
- LAT antibody
- Antibody type
- Polyclonal
- Description
- LAT antibody (Cat. #11326-1-AP) is a rabbit polyclonal antibody that shows reactivity with human, mouse and has been validated for the following applications: IHC, IP, WB,ELISA.
- Reactivity
- Human, Mouse
- Host
- Rabbit
- Conjugate
- Unconjugated
- Isotype
- IgG
- Vial size
- 20ul, 150ul
Submitted references Targeting the TRIM21-PD-1 axis potentiates immune checkpoint blockade and CAR-T cell therapy.
Sterically chained amino acid-rich water-soluble carbon quantum dots as a robust tumor-targeted drug delivery platform.
Baicalein induces apoptosis by inhibiting the glutamine-mTOR metabolic pathway in lung cancer.
The epitranscriptional factor PCIF1 orchestrates CD8(+) T cell ferroptosis and activation to control antitumor immunity.
Pseudogene pair-based prognostic model reveals LAT as a biomarker of immune response in head and neck squamous cell carcinoma.
Cbl-b inhibition promotes less differentiated phenotypes of T cells with enhanced cytokine production.
Cell volume controlled by LRRC8A-formed volume-regulated anion channels fine-tunes T cell activation and function.
Phenylalanine diminishes M1 macrophage inflammation.
Interferon gamma regulates a complex pro-survival signal network in chronic lymphocytic leukemia.
HIF1α/VEGF Feedback Loop Contributes to 5-Fluorouracil Resistance.
Leucine Supplementation in Middle-Aged Male Mice Improved Aging-Induced Vascular Remodeling and Dysfunction via Activating the Sirt1-Foxo1 Axis.
A ceRNA-associated risk model predicts the poor prognosis for head and neck squamous cell carcinoma patients.
Upregulation of CD147 protects hepatocellular carcinoma cell from apoptosis through glycolytic switch via HIF-1 and MCT-4 under hypoxia.
Shi J, Zhang Z, Chen HY, Yao Y, Ke S, Yu K, Shi J, Xiao X, He C, Xiang B, Sun Y, Gao M, Xing X, Yu H, Wang X, Yuan WC, Budiarto BR, Chen SY, Zhang T, Lee YR, Zhu H, Zhang J
Molecular therapy : the journal of the American Society of Gene Therapy 2025 Mar 5;33(3):1073-1090
Molecular therapy : the journal of the American Society of Gene Therapy 2025 Mar 5;33(3):1073-1090
Sterically chained amino acid-rich water-soluble carbon quantum dots as a robust tumor-targeted drug delivery platform.
Xie W, Wang H, Xu H, Su W, Yuan T, Chang J, Bai Y, Fan Y, Zhang Y, Li Y, Li X, Fan L
Nature communications 2025 Mar 19;16(1):2716
Nature communications 2025 Mar 19;16(1):2716
Baicalein induces apoptosis by inhibiting the glutamine-mTOR metabolic pathway in lung cancer.
Li J, Zhang D, Wang S, Yu P, Sun J, Zhang Y, Meng X, Li J, Xiang L
Journal of advanced research 2025 Feb;68:341-357
Journal of advanced research 2025 Feb;68:341-357
The epitranscriptional factor PCIF1 orchestrates CD8(+) T cell ferroptosis and activation to control antitumor immunity.
Xiang B, Zhang M, Li K, Zhang Z, Liu Y, Gao M, Wang X, Xiao X, Sun Y, He C, Shi J, Fan H, Xing X, Xu G, Yao Y, Chen G, Zhu H, Yi C, Zhang J
Nature immunology 2025 Feb;26(2):252-264
Nature immunology 2025 Feb;26(2):252-264
Pseudogene pair-based prognostic model reveals LAT as a biomarker of immune response in head and neck squamous cell carcinoma.
Ding Q, Hong W, Chen G, Lin T, Chen X, Yang H, Xu W, Hong X, Lai J, Qiu S, Lu J
Discover oncology 2025 Aug 11;16(1):1528
Discover oncology 2025 Aug 11;16(1):1528
Cbl-b inhibition promotes less differentiated phenotypes of T cells with enhanced cytokine production.
Wang J, Han X, Hao Y, Chen S, Pang B, Zou L, Han X, Wang W, Liu L, Shen M, Jin A
Cellular immunology 2024 Sep-Oct;403-404:104863
Cellular immunology 2024 Sep-Oct;403-404:104863
Cell volume controlled by LRRC8A-formed volume-regulated anion channels fine-tunes T cell activation and function.
Wang Y, Sun Z, Ping J, Tang J, He B, Chang T, Zhou Q, Yuan S, Tang Z, Li X, Lu Y, He R, He X, Liu Z, Yin L, Wu N
Nature communications 2023 Nov 4;14(1):7075
Nature communications 2023 Nov 4;14(1):7075
Phenylalanine diminishes M1 macrophage inflammation.
Zhang Q, Chen S, Guo Y, He F, Fu J, Ren W
Science China. Life sciences 2023 Dec;66(12):2862-2876
Science China. Life sciences 2023 Dec;66(12):2862-2876
Interferon gamma regulates a complex pro-survival signal network in chronic lymphocytic leukemia.
Chen Y, Shao X, Yang H, Ren L, Cui Y, Zhang W, Macip S, Meng X
European journal of haematology 2023 Apr;110(4):435-443
European journal of haematology 2023 Apr;110(4):435-443
HIF1α/VEGF Feedback Loop Contributes to 5-Fluorouracil Resistance.
Shi B, Xu FF, Xiang CP, Li CY, Fan P, Wang H
Frontiers in pharmacology 2022;13:851401
Frontiers in pharmacology 2022;13:851401
Leucine Supplementation in Middle-Aged Male Mice Improved Aging-Induced Vascular Remodeling and Dysfunction via Activating the Sirt1-Foxo1 Axis.
Hao Z, Xu G, Yuan M, Tan R, Xia Y, Liu Y, Yin X
Nutrients 2022 Sep 17;14(18)
Nutrients 2022 Sep 17;14(18)
A ceRNA-associated risk model predicts the poor prognosis for head and neck squamous cell carcinoma patients.
Xu Y, Xu F, Lv Y, Wang S, Li J, Zhou C, Jiang J, Xie B, He F
Scientific reports 2021 Mar 18;11(1):6374
Scientific reports 2021 Mar 18;11(1):6374
Upregulation of CD147 protects hepatocellular carcinoma cell from apoptosis through glycolytic switch via HIF-1 and MCT-4 under hypoxia.
Ke X, Chen Y, Wang P, Xing J, Chen Z
Hepatology international 2014 Jul;8(3):405-14
Hepatology international 2014 Jul;8(3):405-14
No comments: Submit comment
Supportive validation
- Submitted by
- Proteintech Group (provider)
- Main image
- Experimental details
- The LAT antibody from Proteintech is a rabbit polyclonal antibody to a recombinant protein of human LAT. This antibody recognizes human antigen. The LAT antibody has been validated for the following applications: ELISA, WB analysis.
